Back to top

Image: Bigstock

Top Ranked Momentum Stocks to Buy for January 13th

Read MoreHide Full Article

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, January 13th:

Silicon Motion Technology Corporation (SIMO - Free Report) : This company that designs, develops, and markets NAND flash controllers for solid state storage devices has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.6% over the last 60 days.          

Silicon Motion Technology’s shares gained 8.6% over the last one month above the S&P 500’s increase 3%. The company possesses a Momentum Score of A.

Virtus Investment Partners, Inc. (VRTS - Free Report) : This investment management company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.5% over the last 60 days.

Virtus Investment Partners’ shares gained 7.4% over the last one month. The company possesses a Momentum Score of A.

Teekay Tankers Ltd. (TNK - Free Report) : This company provides marine transportation services to oil industries in Bermuda and internationally has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 23.6% over the last 60 days.

Teekay Tankers’ shares gained 6.2% over the last one month. The company possesses a Momentum Score of A.

Zumiez Inc. (ZUMZ - Free Report) : This specialty retailer of apparel, footwear, accessories, and hardgoods for young men and women has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing nearly 13% over the last 60 days.

Zumiez Inc. Price and Consensus

Zumiez Inc. Price and Consensus

Zumiez Inc. price-consensus-chart | Zumiez Inc. Quote

Zumiez’s shares gained 13.9% over the last one month. The company possesses a Momentum Score of A.

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>